Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1948 2
1949 1
1950 2
1951 3
1952 3
1953 7
1954 6
1956 3
1957 8
1958 8
1959 3
1960 2
1961 13
1962 19
1963 24
1964 32
1965 33
1966 26
1967 43
1968 56
1969 57
1970 45
1971 50
1972 39
1973 48
1974 52
1975 54
1976 47
1977 44
1978 66
1979 51
1980 64
1981 76
1982 74
1983 79
1984 76
1985 80
1986 97
1987 93
1988 95
1989 99
1990 98
1991 81
1992 102
1993 99
1994 121
1995 134
1996 156
1997 155
1998 183
1999 181
2000 199
2001 220
2002 221
2003 204
2004 243
2005 273
2006 295
2007 297
2008 262
2009 309
2010 350
2011 351
2012 392
2013 418
2014 483
2015 469
2016 458
2017 429
2018 423
2019 474
2020 591
2021 671
2022 590
2023 564
2024 558
2025 506
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,092 results

Results by year

Filters applied: . Clear all
Page 1
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. Among authors: ito t. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Free article. Clinical Trial.
Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, Kanno A, Kida M, Sakagami J, Sata N, Takeyama Y, Tahara J, Hirota M, Fujimori N, Masamune A, Mochida S, Enomoto N, Shimosegawa T, Koike K. Shimizu K, et al. Among authors: ito t. J Gastroenterol. 2022 Oct;57(10):709-724. doi: 10.1007/s00535-022-01911-6. Epub 2022 Aug 22. J Gastroenterol. 2022. PMID: 35994093 Free PMC article. Review.
Clonal germinal center B cells function as a niche for T-cell lymphoma.
Fujisawa M, Nguyen TB, Abe Y, Suehara Y, Fukumoto K, Suma S, Makishima K, Kaneko C, Nguyen YTM, Usuki K, Narita K, Matsue K, Nakamura N, Ishikawa S, Miura F, Ito T, Suzuki A, Suzuki Y, Mizuno S, Takahashi S, Chiba S, Sakata-Yanagimoto M. Fujisawa M, et al. Among authors: ito t. Blood. 2022 Nov 3;140(18):1937-1950. doi: 10.1182/blood.2022015451. Blood. 2022. PMID: 35921527 Free PMC article.
Taurine from tumour niche drives glycolysis to promote leukaemogenesis.
Sharma S, Rodems BJ, Baker CD, Kaszuba CM, Franco EI, Smith BR, Ito T, Swovick K, Welle K, Zhang Y, Rock P, Chaves FA, Ghaemmaghami S, Calvi LM, Ganguly A, Burack WR, Becker MW, Liesveld JL, Brookes PS, Munger JC, Jordan CT, Ashton JM, Bajaj J. Sharma S, et al. Among authors: ito t. Nature. 2025 Aug;644(8075):263-272. doi: 10.1038/s41586-025-09018-7. Epub 2025 May 14. Nature. 2025. PMID: 40369079 Free PMC article.
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O, Senna MM, Sinclair R, Ito T, Dutronc Y, Lin CY, Yu G, Chiasserini C, McCollam J, Wu WS, King B. Kwon O, et al. Among authors: ito t. Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1. Am J Clin Dermatol. 2023. PMID: 36855020 Free PMC article. Clinical Trial.
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation.
Li B, Sakaguchi T, Tani H, Ito T, Murakami M, Okumura R, Kobayashi M, Okuzaki D, Motooka D, Ikeuchi H, Ogino T, Mizushima T, Hirota S, Otake-Kasamoto Y, Kishikawa T, Nakamura S, Kobiyama K, Ishii KJ, Hashiguchi T, Kawai T, Kuroda E, Shinzaki S, Ise W, Kurosaki T, Kikuchi A, Tomofuji Y, Okada Y, Takeda K, Kayama H. Li B, et al. Among authors: ito t. Sci Immunol. 2025 Jul 18;10(109):eadm6843. doi: 10.1126/sciimmunol.adm6843. Epub 2025 Jul 18. Sci Immunol. 2025. PMID: 40680146
[ICI-induced liver injury].
Ito T, Kawashima H. Ito T, et al. Nihon Shokakibyo Gakkai Zasshi. 2024;121(12):948-956. doi: 10.11405/nisshoshi.121.948. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 39662922 Japanese. No abstract available.
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.
Kometani K, Yorimitsu T, Jo N, Yamaguchi E, Kikuchi O, Fukahori M, Sawada T, Tsujimoto Y, Sunami A, Li M, Ito T, Pretemer Y, Gao Y, Hidaka Y, Yamamoto M, Kaku N, Nakagama Y, Kido Y, Grifoni A, Sette A, Nagao M, Morita S, Nakajima TE, Muto M, Hamazaki Y. Kometani K, et al. Among authors: ito t. Front Immunol. 2024 Dec 9;15:1455334. doi: 10.3389/fimmu.2024.1455334. eCollection 2024. Front Immunol. 2024. PMID: 39717779 Free PMC article.
12,092 results
You have reached the last available page of results. Please see the User Guide for more information.